HSBC Initiates Coverage On Amgen with Buy Rating, Announces Price Target of $320
Portfolio Pulse from Benzinga Newsdesk
HSBC analyst Morten Herholdt has initiated coverage on Amgen (NASDAQ:AMGN) with a Buy rating and a price target of $320.
September 06, 2023 | 9:09 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HSBC has initiated coverage on Amgen with a Buy rating and a price target of $320, which could positively impact the stock's performance.
Analyst ratings and price targets can significantly influence a stock's performance. In this case, HSBC's Buy rating and high price target for Amgen suggest a positive outlook for the stock, which could attract investors and drive up the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100